Today we will finish our discussion with a very controversial topic: when to pull epidural catheters in patients receiving warfarin or Low Molecular Weight Heparin (LMWH) prophylaxis.
今天我们通过一非常有争议的话题结束讨论：对于接受华发林或LMWH预防性治疗的患者什么时候拔除硬膜外导管。
Objective To explore the application of low-molecular-weight heparin (LMWH) in the procedure of coronary stent implantation.
目的探讨低分子肝素(LMWH)在冠状动脉支架术中的应用价值及安全性。
Objective To evaluate the efficacy and safety of low-molecular-weight heparin(LMWH) in preventing for deep-vein thrombosis (DVT) after total hip replace(THR).
目的探讨人工髋关节置换术（THR）后用低分子肝素预防下肢深静脉血栓（DVT）形成的疗效和安全性。
The immunocompetence of low molecular weight heparin(LMWH) derived from low anticoagulant activity heparin(LAAH), a by-product in commercial heparin production, was studied.
对比研究了低抗凝活性肝素、商品肝素及以低抗凝活性肝素为原料制得的低分子肝素的免疫活性。
Objective The aim of this study were to evaluate the value of activated partial thromboplastin time(APTT) in monitoring low-molecular weight heparin(LMWH).
目的进一步探讨活化的部分凝血活酶时间（APTT）对低分子量肝素（LMWH）治疗的实验监测价值。
Objective To observe the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of primary nephrotic syndrome.
目的观察低分子量肝素对原发性肾病综合征的治疗作用。
Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulability in acute Kawasaki disease(KD).
目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。
AIM To test gelatin microspheres of low molecular weight heparin (LMWH-GMS) release behavior; lung target behavior and stability.
目的考察低分子肝素肺靶向微球缓释性、稳定性和靶向性。
AIM: To study the effect and safety of low-molecular-weight heparin (LMWH) in the treatment of acute ischemic stroke.
目的：评价低分子肝素(LMWH)治疗急性缺血性中风的疗效和安全性。
Objective to evaluate the efficacy and safety of low molecular weight heparin (LMWH) in prophylaxis of postoperative deep vein thrombosis (DVT) following hip and knee surgery.
目的评价低分子肝素预防髋、膝关节术后深静脉血栓形成(DVT)的疗效和安全性。
Purpose To study purification method of the low molecular weight heparin(LMWH) by affinity chromatography.
目的探索亲和色谱纯化低分子肝素的方法。
Objective To observe the curative effect of different dosages of low molecular weight heparin (LMWH) in patients with acute cerebral infarction (ACI).
目的观察不同剂量低分子肝素(LMWH)对急性脑梗死(aci)患者的疗效。
Objective to determine the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of unstable angina pectoris (UAP).
目的探讨低分子质量肝素(LMWH)治疗不稳定型心绞痛(uap)效果。
Objective To explore thrombolysis action of low molecular weight heparin (LMWH).
目的探讨低分子肝素(L MWH)的溶栓作用。
Objective To evaluate the effects of low molecular weight heparin (LMWH) on serum interleukin-8 (IL-8) in patients with primary nephrotic syndrome (PNS).
目的观察低分子肝素钠对原发性肾病综合征(PNS)患者血浆白介素- 8 (IL - 8)的影响。
Objective To investigate the relationship between local compression and local hemorrhage after low molecular weight heparin (LMWH) subcutaneous injection.
目的探讨低分子肝素(LMWH)皮下注射后局部压迫与否与局部出血的关系。
AIM: to investigate the mechanism by which low molecular weight heparin (LMWH) inhibits apoptosis of primary cultured cerebral cortical neurons caused by hypoxia.
目的：探讨低分子肝素对体外培养的新生大鼠大脑皮层神经细胞缺氧性凋亡的作用机制。
OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin (LMWH).
目的测定低分子肝素的分子量及其分布。
OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin (LMWH).
目的测定低分子肝素的分子量及其分布。
应用推荐